Inari Medical, Inc.
$179 Million Initial Public Offering
In May 2020, ICR Westwicke began an engagement with Inari Medical, Inc., a commercial-stage medical device company, to assist the company with its IPO. After much preparation and an exceptionally successful four-day virtual roadshow, Inari shares closed up 124% on the first day of trading. That first-day trading performance ranks #1 among MedTech IPOs of the last decade.
Download the case study for more details on how ICR Westwicke’s guidance led to the highest file/offer performance for a healthcare IPO since 2015.